Chemed (CHE) Debt to Equity (2009 - 2026)

Chemed (CHE) has reported Debt to Equity for 16 consecutive years, with $0.11 the latest figure, recorded in Q1 2026.

• In Q1 2026, Debt to Equity changed N/A year-over-year to $0.11; the TTM figure through Mar 2026 stood at $0.11 (changed N/A YoY), while the FY2022 annual figure was $0.12, down 58.87% from the prior year.
• Debt to Equity came in at $0.11 for Q1 2026 at Chemed, up from $0.02 in the prior quarter.
• The five-year high for Debt to Equity was $0.18 in Q1 2022, with the low at $0.02 in Q1 2023.
• Average Debt to Equity over 3 years is $0.12, with a median of $0.13 recorded in 2022.
• Across the five-year window, Debt to Equity slumped 58.87% in 2022 and sank 86.58% in 2023, its largest moves.
• Year by year, Debt to Equity stood at $0.12 in 2022, then tumbled by 80.22% to $0.02 in 2023, then soared by 345.4% to $0.11 in 2026.
• According to Business Quant data, Debt to Equity over the past three periods registered $0.11, $0.02, and $0.12 for Q1 2026, Q1 2023, and Q4 2022 respectively.